🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to learn about the effects of LY3074828 when g...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2019-03-27
Trial ID
NCT03886948
Treatments Being Tested
The purpose of this study is to look at the amount of the study drug, LY307...
Status
Completed
Location
Covance Clinical Research Inc
Start Date
2018-09-06
Trial ID
NCT03662100
Treatments Being Tested
The main purpose of this study is to evaluate amount of mirikizumab (test) ...
Status
Completed
Location
Altasciences Clinical Los Angeles, Inc
Start Date
2022-08-31
Trial ID
NCT05515601
Treatments Being Tested
The purpose of this study is to look at the amount of the study drug, LY307...
Status
Completed
Location
Covance
Start Date
2017-06-30
Trial ID
NCT03188510
Treatments Being Tested
The purpose of this study is to look at the amount of the study drug, LY307...
Status
Completed
Location
Covance
Start Date
2018-03-06
Trial ID
NCT03456713
Treatments Being Tested
The main purpose of this study is to evaluate amount of mirikizumab (test) ...
Status
Completed
Location
Altasciences Clinical Los Angeles, Inc
Start Date
2022-12-05
Trial ID
NCT05644353
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Recruiting
Location
Fortrea Clinical Research Unit
Start Date
2026-03-24
Trial ID
NCT07446101
Treatments Being Tested
This study is conducted to compare how much mirikizumab, in two different f...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2017-04-24
Trial ID
NCT03053622
Treatments Being Tested
The purpose of this study is to compare two different formulations of mirik...
Status
Completed
Location
QPS
Start Date
2020-09-11
Trial ID
NCT04548219
Treatments Being Tested
The purpose of this study is to evaluate the amount of mirikizumab (test) t...
Status
Completed
Location
CenExel ACT
Start Date
2024-06-24
Trial ID
NCT06475729
Treatments Being Tested